เกี่ยวกับตอนนี้
Today's episode looks at three research papers: a breast cancer surgery trial about whether women with early-stage lobular carcinoma still need lymph node biopsies, a commentary pushing back on a bone-drug study in postmenopausal Chinese women, and a screening tool analysis that quietly raises questions about who gets flagged for osteoporosis — and who doesn't.
Key Takeaways:
• The SOUND trial showed that many women with early-stage breast cancer can skip sentinel lymph node biopsy, but a new analysis questions whether those findings apply to a specific breast cancer type called invasive lobular carcinoma, which has a higher rate of lymph node involvement than other early-stage cancers.
• Eldecalcitol is a vitamin D analog used for postmenopausal osteoporosis in Japan and studied in Chinese women; a new commentary flags methodological concerns in the supporting study, including the lack of a control group and short follow-up — important caveats before anyone treats this as settled evidence.
• Osteoporosis screening tools developed and validated in one population often underperform in others; a Japanese men's study is a reminder that fracture risk calculators need to be tested — not assumed — in the groups they're used for.
• The gender gap in osteoporosis research runs in both directions: women are underrepresented in cardiovascular trials, but men are often underrepresented in bone health research, which means screening tools calibrated on women may miss at-risk men entirely.
• None of these papers are practice-changing on their own, but each one is the kind of evidence your doctor would weigh when making a specific call — the kind of thing worth knowing so you can ask better questions.
Sources & References:
• Axillary node upstaging in lobular breast cancer — can the SOUND trial results apply? (https://pubmed.ncbi.nlm.nih.gov/42802378/) - PubMed
• Commentary on eldecalcitol and calcium supplementation for postmenopausal osteoporosis in Chinese women (https://pubmed.ncbi.nlm.nih.gov/42802291/) - PubMed
• How well do osteoporosis screening tools work in elderly Japanese men? (https://pubmed.ncbi.nlm.nih.gov/42802288/) - PubMed
Listen with full show notes: https://hotflasher.com/episodes/2026-09-28-research-roundup
Have a menopause story to share? We'd love to hear it:
https://hotflasher.com/share
---
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.
Key Takeaways:
• The SOUND trial showed that many women with early-stage breast cancer can skip sentinel lymph node biopsy, but a new analysis questions whether those findings apply to a specific breast cancer type called invasive lobular carcinoma, which has a higher rate of lymph node involvement than other early-stage cancers.
• Eldecalcitol is a vitamin D analog used for postmenopausal osteoporosis in Japan and studied in Chinese women; a new commentary flags methodological concerns in the supporting study, including the lack of a control group and short follow-up — important caveats before anyone treats this as settled evidence.
• Osteoporosis screening tools developed and validated in one population often underperform in others; a Japanese men's study is a reminder that fracture risk calculators need to be tested — not assumed — in the groups they're used for.
• The gender gap in osteoporosis research runs in both directions: women are underrepresented in cardiovascular trials, but men are often underrepresented in bone health research, which means screening tools calibrated on women may miss at-risk men entirely.
• None of these papers are practice-changing on their own, but each one is the kind of evidence your doctor would weigh when making a specific call — the kind of thing worth knowing so you can ask better questions.
Sources & References:
• Axillary node upstaging in lobular breast cancer — can the SOUND trial results apply? (https://pubmed.ncbi.nlm.nih.gov/42802378/) - PubMed
• Commentary on eldecalcitol and calcium supplementation for postmenopausal osteoporosis in Chinese women (https://pubmed.ncbi.nlm.nih.gov/42802291/) - PubMed
• How well do osteoporosis screening tools work in elderly Japanese men? (https://pubmed.ncbi.nlm.nih.gov/42802288/) - PubMed
Listen with full show notes: https://hotflasher.com/episodes/2026-09-28-research-roundup
Have a menopause story to share? We'd love to hear it:
https://hotflasher.com/share
---
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.
ภาษาอังกฤษ
สหรัฐอเมริกา
สำเนาบทสนทนา 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
ตอนอื่นๆ ใน PODCAST นี้
This episode covers three wellness angles worth taking into the weekend: why estrogen loss reshapes your gut microbiome and what to do about it, why bone loss is so easy to miss until something breaks, and why a nutritionist's argument that eating enough is a "radical act" is more than just a catch…
ACOG updated its menopause treatment guidelines for the first time since 2014, and several old assumptions didn't survive the revision. This episode also covers a new systematic review on non-hormonal treatments for depression and anxiety during perimenopause and postmenopause, and a strengthened A…
This episode covers three things getting a lot of attention right now: new research on menopause symptoms pushing women out of the workforce, a Cambridge University study on how often women's autoimmune symptoms get dismissed as psychological, and a dermatologist-backed breakdown of what actually w…
This episode covers three new studies from mid-to-late 2026: what women with PCOS say their experience actually looks like, how your sleep pattern over years — not just last night — connects to heart, kidney, and metabolic disease risk, and what postmenopausal women's diets have to do with their de…
Three new studies land this week with a shared theme the researchers didn't plan: the menopausal transition affects the brain and heart in ways that start earlier, run deeper, and differ more by sex than medicine has historically acknowledged. Nykki breaks down what a vulnerability window before de…
ข้อสงวนสิทธิ์: พอดแคสต์และอาร์ตเวิร์คที่ฝังอยู่ในหน้านี้มาจาก Hot Flasher ซึ่งเป็นทรัพย์สินของเจ้าของและไม่มีส่วนเกี่ยวข้องหรือรับรองโดย Listen Notes, Inc.